Scott G. Davis - 10 Nov 2025 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role: CEO, Director
Signature: /s/ Jerome Wong
Issuer symbol: EKSO
Transactions as of: 10 Nov 2025
Transactions value $: -$111,912
Form type: 4
Filing time: 12 Nov 2025, 17:04:28 UTC
Previous filing: 07 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Davis Scott G.	CEO, Director	101 GLACIER POINT, SUITE A, SAN RAFAEL	/s/ Jerome Wong	12 Nov 2025	0001908860

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EKSO	Common Stock	Sale	-$112K	-23.3K	-22.84%	$4.80	78.8K	10 Nov 2025	Direct	F1, F2, F3
holding	EKSO	Common Stock						373	10 Nov 2025	By 401(k)	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares sold by the Reporting Person on November 10, 2025 to cover tax withholding obligations incurred upon the vesting and settlement of restricted stock awards originally reported by the Reporting Person in Form 4 filed with the Commission on November 7, 2025.
F2	These shares were sold in a single transaction at a price of $4.7990 per share.
F3	On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.